What is Intramuscular Drug Delivery?
An intramuscular injection is a method of injecting drugs into the muscles. This allows for rapid absorption of the medicine into the bloodstream. Such as the flu shot, people may have received an intramuscular injection at a doctor's office. In rare situations, an intramuscular injection can be self-administered. Certain medications used to treat multiple sclerosis or rheumatoid arthritis, for example, may require self-injection. The intramuscular method is faster than the subcutaneous route in terms of absorption, and muscle tissue can often absorb a higher volume of fluid without causing discomfort. Medication injected into muscle tissues, on the other side, is absorbed more slowly and takes longer to take action than medication administered intravenously.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Antares Pharma (United States), Pfizer (United States), Johnson & Johnson (United States), Eli Lily (United States), Glaxo SmithKline (United Kingdom), Inovio Pharmaceuticals (United States), Merck (United States), Novartis (Switzerland), Pacira Pharmaceuticals (United States) and Pharmajet (Unite States) |
The study covers a detailed analysis segmented by key business segments i.e. by type (Oral (Swallowed Into The Stomach), Intravenous (Injected Into The Vein) and Subcutaneous (Injected Into The Fatty Tissue Just Under The Layer Of Skin)) , by application (Infectious Disease, Oncology, Autoimmune Disease, Allergy, Endocrinology Disorders and Others) and major geographies.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Intramuscular Drug Delivery market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Antares Pharma (United States), Pfizer (United States), Johnson & Johnson (United States), Eli Lily (United States), Glaxo SmithKline (United Kingdom), Inovio Pharmaceuticals (United States), Merck (United States), Novartis (Switzerland), Pacira Pharmaceuticals (United States) and Pharmajet (Unite States).
Market Overview:
In April 2022, Halozyme acquired Antares Pharma to create a specialty leader and drug delivery company. Antares Pharma is a leading specialty pharmaceutical company that manufactures drug delivery solutions. The acquisition will strengthen Halozyme's position in the global drug delivery market.
In 2021, FDA approved CABENUVA for intramuscular use as a complete treatment for adults with HIV-1. According to guidelines initial doses should be a single 600-mg gluteal intramuscular injection of cabotegravir and a single 900-mg gluteal intramuscular injection of rilpivirine after that continuation injection doses will be 400-mg and 600 mg for cabotegravir and rilpivirine respectively.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Intramuscular Drug Delivery Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Increasing Prevalence Of Chronic Diseases
- Increasing Demand Of Self-Administered Drug Delivery Injection
|
Major Trends | - Growth In Healthcare Infrastructure Across Emerging Regions
- Increase The Investment In Artificial Intelligence For Metastatic Ovarian Cancer Drug
|
Restraints | - IM Drug Delivery Absorption Is Relatively Low As Compared To IV Rout
|
Road Blocks / Challenges | - IM Delivery Causes The Allergies Depending On The Drug Used And The Patient's Vulnerability To Various Allergens
|
Gaps & Opportunities | - Rising Investment In Research & Development Costs In The Pharmaceutical Industries
- Favorable Government Initiatives
|
Key highlights of the Global Intramuscular Drug Delivery market Study:
CAGR of the market during the forecast period 2021-2027
In-depth information on growth factors that will accelerate the Intramuscular Drug Delivery market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Intramuscular Drug Delivery market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Intramuscular Drug Delivery Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Intramuscular Drug Delivery market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Intramuscular Drug Delivery market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Intramuscular Drug Delivery Provider, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.